IBDEI2BF ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,36985,0)
;;=96405^^143^1892^1^^^^1
;;^UTILITY(U,$J,358.3,36985,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36985,1,2,0)
;;=2^96405
;;^UTILITY(U,$J,358.3,36985,1,3,0)
;;=3^Chemo Intralesional Up to 7
;;^UTILITY(U,$J,358.3,36986,0)
;;=11901^^143^1892^9^^^^1
;;^UTILITY(U,$J,358.3,36986,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36986,1,2,0)
;;=2^11901
;;^UTILITY(U,$J,358.3,36986,1,3,0)
;;=3^Skin Lesion Injection,Addl Lesions
;;^UTILITY(U,$J,358.3,36987,0)
;;=11900^^143^1892^10^^^^1
;;^UTILITY(U,$J,358.3,36987,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36987,1,2,0)
;;=2^11900
;;^UTILITY(U,$J,358.3,36987,1,3,0)
;;=3^Skin Lesion Injection,Up to 7 Lesions
;;^UTILITY(U,$J,358.3,36988,0)
;;=Q2026^^143^1892^7^^^^1
;;^UTILITY(U,$J,358.3,36988,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36988,1,2,0)
;;=2^Q2026
;;^UTILITY(U,$J,358.3,36988,1,3,0)
;;=3^Radiesse Inj 0.1 ml
;;^UTILITY(U,$J,358.3,36989,0)
;;=Q2028^^143^1892^8^^^^1
;;^UTILITY(U,$J,358.3,36989,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36989,1,2,0)
;;=2^Q2028
;;^UTILITY(U,$J,358.3,36989,1,3,0)
;;=3^Sculptra Inj 0.5mg
;;^UTILITY(U,$J,358.3,36990,0)
;;=G0429^^143^1892^3^^^^1
;;^UTILITY(U,$J,358.3,36990,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36990,1,2,0)
;;=2^G0429
;;^UTILITY(U,$J,358.3,36990,1,3,0)
;;=3^Dermal Filler Inj Px/Supply
;;^UTILITY(U,$J,358.3,36991,0)
;;=J0135^^143^1892^4^^^^1
;;^UTILITY(U,$J,358.3,36991,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36991,1,2,0)
;;=2^J0135
;;^UTILITY(U,$J,358.3,36991,1,3,0)
;;=3^Humira (Adalimumab) 20mg
;;^UTILITY(U,$J,358.3,36992,0)
;;=J3301^^143^1892^5^^^^1
;;^UTILITY(U,$J,358.3,36992,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36992,1,2,0)
;;=2^J3301
;;^UTILITY(U,$J,358.3,36992,1,3,0)
;;=3^Kenalog (Triamcinolone Acetonide) 10mg
;;^UTILITY(U,$J,358.3,36993,0)
;;=J7308^^143^1892^6^^^^1
;;^UTILITY(U,$J,358.3,36993,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36993,1,2,0)
;;=2^J7308
;;^UTILITY(U,$J,358.3,36993,1,3,0)
;;=3^Levulan Kerasticks (Aminolevulinic Acid Hcl) 20%
;;^UTILITY(U,$J,358.3,36994,0)
;;=J3357^^143^1892^11^^^^1
;;^UTILITY(U,$J,358.3,36994,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36994,1,2,0)
;;=2^J3357
;;^UTILITY(U,$J,358.3,36994,1,3,0)
;;=3^Stelara (Ustekinumab) 1 mg
;;^UTILITY(U,$J,358.3,36995,0)
;;=15780^^143^1893^6^^^^1
;;^UTILITY(U,$J,358.3,36995,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36995,1,2,0)
;;=2^15780
;;^UTILITY(U,$J,358.3,36995,1,3,0)
;;=3^Dermabrasion,Total Face
;;^UTILITY(U,$J,358.3,36996,0)
;;=15781^^143^1893^2^^^^1
;;^UTILITY(U,$J,358.3,36996,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36996,1,2,0)
;;=2^15781
;;^UTILITY(U,$J,358.3,36996,1,3,0)
;;=3^Dermabrasion,Segmental,Face
;;^UTILITY(U,$J,358.3,36997,0)
;;=15782^^143^1893^1^^^^1
;;^UTILITY(U,$J,358.3,36997,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36997,1,2,0)
;;=2^15782
;;^UTILITY(U,$J,358.3,36997,1,3,0)
;;=3^Dermabrasion,Regional,Not Face
;;^UTILITY(U,$J,358.3,36998,0)
;;=15783^^143^1893^5^^^^1
;;^UTILITY(U,$J,358.3,36998,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36998,1,2,0)
;;=2^15783
;;^UTILITY(U,$J,358.3,36998,1,3,0)
;;=3^Dermabrasion,Superficial
;;^UTILITY(U,$J,358.3,36999,0)
;;=15786^^143^1893^3^^^^1
;;^UTILITY(U,$J,358.3,36999,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36999,1,2,0)
;;=2^15786
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2BF 3765 printed Apr 09, 2024@21:46:28 Page 2
IBDEI2BF ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,36985,0)
+2 ;;=96405^^143^1892^1^^^^1
+3 ;;^UTILITY(U,$J,358.3,36985,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,36985,1,2,0)
+6 ;;=2^96405
+7 ;;^UTILITY(U,$J,358.3,36985,1,3,0)
+8 ;;=3^Chemo Intralesional Up to 7
+9 ;;^UTILITY(U,$J,358.3,36986,0)
+10 ;;=11901^^143^1892^9^^^^1
+11 ;;^UTILITY(U,$J,358.3,36986,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,36986,1,2,0)
+14 ;;=2^11901
+15 ;;^UTILITY(U,$J,358.3,36986,1,3,0)
+16 ;;=3^Skin Lesion Injection,Addl Lesions
+17 ;;^UTILITY(U,$J,358.3,36987,0)
+18 ;;=11900^^143^1892^10^^^^1
+19 ;;^UTILITY(U,$J,358.3,36987,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,36987,1,2,0)
+22 ;;=2^11900
+23 ;;^UTILITY(U,$J,358.3,36987,1,3,0)
+24 ;;=3^Skin Lesion Injection,Up to 7 Lesions
+25 ;;^UTILITY(U,$J,358.3,36988,0)
+26 ;;=Q2026^^143^1892^7^^^^1
+27 ;;^UTILITY(U,$J,358.3,36988,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,36988,1,2,0)
+30 ;;=2^Q2026
+31 ;;^UTILITY(U,$J,358.3,36988,1,3,0)
+32 ;;=3^Radiesse Inj 0.1 ml
+33 ;;^UTILITY(U,$J,358.3,36989,0)
+34 ;;=Q2028^^143^1892^8^^^^1
+35 ;;^UTILITY(U,$J,358.3,36989,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,36989,1,2,0)
+38 ;;=2^Q2028
+39 ;;^UTILITY(U,$J,358.3,36989,1,3,0)
+40 ;;=3^Sculptra Inj 0.5mg
+41 ;;^UTILITY(U,$J,358.3,36990,0)
+42 ;;=G0429^^143^1892^3^^^^1
+43 ;;^UTILITY(U,$J,358.3,36990,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,36990,1,2,0)
+46 ;;=2^G0429
+47 ;;^UTILITY(U,$J,358.3,36990,1,3,0)
+48 ;;=3^Dermal Filler Inj Px/Supply
+49 ;;^UTILITY(U,$J,358.3,36991,0)
+50 ;;=J0135^^143^1892^4^^^^1
+51 ;;^UTILITY(U,$J,358.3,36991,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,36991,1,2,0)
+54 ;;=2^J0135
+55 ;;^UTILITY(U,$J,358.3,36991,1,3,0)
+56 ;;=3^Humira (Adalimumab) 20mg
+57 ;;^UTILITY(U,$J,358.3,36992,0)
+58 ;;=J3301^^143^1892^5^^^^1
+59 ;;^UTILITY(U,$J,358.3,36992,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,36992,1,2,0)
+62 ;;=2^J3301
+63 ;;^UTILITY(U,$J,358.3,36992,1,3,0)
+64 ;;=3^Kenalog (Triamcinolone Acetonide) 10mg
+65 ;;^UTILITY(U,$J,358.3,36993,0)
+66 ;;=J7308^^143^1892^6^^^^1
+67 ;;^UTILITY(U,$J,358.3,36993,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,36993,1,2,0)
+70 ;;=2^J7308
+71 ;;^UTILITY(U,$J,358.3,36993,1,3,0)
+72 ;;=3^Levulan Kerasticks (Aminolevulinic Acid Hcl) 20%
+73 ;;^UTILITY(U,$J,358.3,36994,0)
+74 ;;=J3357^^143^1892^11^^^^1
+75 ;;^UTILITY(U,$J,358.3,36994,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,36994,1,2,0)
+78 ;;=2^J3357
+79 ;;^UTILITY(U,$J,358.3,36994,1,3,0)
+80 ;;=3^Stelara (Ustekinumab) 1 mg
+81 ;;^UTILITY(U,$J,358.3,36995,0)
+82 ;;=15780^^143^1893^6^^^^1
+83 ;;^UTILITY(U,$J,358.3,36995,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,36995,1,2,0)
+86 ;;=2^15780
+87 ;;^UTILITY(U,$J,358.3,36995,1,3,0)
+88 ;;=3^Dermabrasion,Total Face
+89 ;;^UTILITY(U,$J,358.3,36996,0)
+90 ;;=15781^^143^1893^2^^^^1
+91 ;;^UTILITY(U,$J,358.3,36996,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,36996,1,2,0)
+94 ;;=2^15781
+95 ;;^UTILITY(U,$J,358.3,36996,1,3,0)
+96 ;;=3^Dermabrasion,Segmental,Face
+97 ;;^UTILITY(U,$J,358.3,36997,0)
+98 ;;=15782^^143^1893^1^^^^1
+99 ;;^UTILITY(U,$J,358.3,36997,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,36997,1,2,0)
+102 ;;=2^15782
+103 ;;^UTILITY(U,$J,358.3,36997,1,3,0)
+104 ;;=3^Dermabrasion,Regional,Not Face
+105 ;;^UTILITY(U,$J,358.3,36998,0)
+106 ;;=15783^^143^1893^5^^^^1
+107 ;;^UTILITY(U,$J,358.3,36998,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,36998,1,2,0)
+110 ;;=2^15783
+111 ;;^UTILITY(U,$J,358.3,36998,1,3,0)
+112 ;;=3^Dermabrasion,Superficial
+113 ;;^UTILITY(U,$J,358.3,36999,0)
+114 ;;=15786^^143^1893^3^^^^1
+115 ;;^UTILITY(U,$J,358.3,36999,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,36999,1,2,0)
+118 ;;=2^15786
